https://www.selleckchem.com/pr....oducts/anlotinib-al3
Baseline comorbidity was assessed using the CCI, the FCI and the w-FCI. Correlations, receiver operating curves (ROC), and multiple linear regression analyses were performed. The models were adjusted for age, gender and EMS or BI on admission. RESULTS In total, 98 patients (mean age 82 years; 37% male) were included. The areas under the ROC curves of the w-FCI (EMS at discharge 0.72, EMS gain/day 0.72, BI at discharge 0.66 and BI gain/day 0.6 were higher than for the CCI (0.50, 0.53, 0.49, 0.44 respectively) and FCI (0.65, 0.
Like
Comment
Share
